Logo image
FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas
Journal article   Open access   Peer reviewed

FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas

Pichai Raman, Timothy Purwin, Richard Pestell and Aydin Tozeren
Cancer informatics, v 14(2015), pp 113-119
12 Oct 2015
PMID: 26494976
url
https://doi.org/10.4137/cin.s30565View
Published, Version of Record (VoR)CC BY-NC V4.0 Open
url
https://doi.org/10.4137/CIN.S30565View
Published, Version of Record (VoR) Open

Abstract

dysadherin FXYD5 ovarian cancer Short Report survival TCGA
Ovarian cancer (OC) is a leading cause of cancer mortality, but aside from a few well-studied mutations, very little is known about its underlying causes. As such, we performed survival analysis on ovarian copy number amplifications and gene expression datasets presented by The Cancer Genome Atlas in order to identify potential drivers and markers of aggressive OC. Additionally, two independent datasets from the Gene Expression Omnibus web platform were used to validate the identified markers. Based on our analysis, we identified FXYD5 , a glycoprotein known to reduce cell adhesion, as a potential driver of metastasis and a significant predictor of mortality in OC. As a marker of poor outcome, the protein has effective antibodies against it for use in tissue arrays. FXYD5 bridges together a wide variety of cancers, including ovarian, breast cancer stage II, thyroid, colorectal, pancreatic, and head and neck cancers for metastasis studies.

Metrics

25 Record Views
17 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Mathematical & Computational Biology
Oncology
Logo image